XML 43 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 34,092 $ 25,646
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,999 3,196
Noncash stock-based compensation 52,807 47,339
Noncash change in fair value of equity securities (135) (187)
Noncash impairment charges 2,910 0
Noncash operating lease expense 2,948 2,591
Deferred income taxes (8,483) 0
Amortization of deferred commissions cost 15,477 12,749
Changes in operating assets and liabilities:    
Trade accounts receivable, net 23,113 8,245
Operating lease liabilities (3,973) (2,526)
Other current assets and Other assets (4,342) (3,832)
Deferred commissions cost (17,420) (12,561)
Accounts payable (205) 32
Accrued liabilities (11,832) (3,963)
Deferred revenue 11,830 1,746
Other liabilities (505) 899
Net cash provided by operating activities 100,281 79,374
Cash flows from investing activities    
Purchase of property and equipment (2,711) (1,413)
Purchase of equity securities (581) (572)
Business combination, net of cash acquired (21,000) 0
Net cash used in investing activities (24,292) (1,985)
Cash flows from financing activities    
Repurchase of common stock (103,295) (82,357)
Proceeds from stock-based compensation plans 11,100 6,368
Net cash used in financing activities (92,195) (75,989)
Effects of exchange rate — changes in cash 6,523 (5,891)
Net decrease in cash and cash equivalents (9,683) (4,491)
Cash and cash equivalents at beginning of period 312,754 287,778
Cash and cash equivalents at end of period 303,071 283,287
Supplemental disclosures of noncash activities    
Issuance of common stock for business combination 4,900 0
Operating lease liabilities arising from obtaining right-of-use assets $ 4,467 $ 4,695